Research

For the most up to date list of publications, check out my Google Scholar page.

Peer-reviewed Publications

DD Sjoberg, K Whiting, M Curry, JA Lavery, J Larmarange (2021). “Reproducible Summary Tables with the gtsummary Package.” The R Journal, 13 (1), 570-580

DD Sjoberg, AJ Vickers, M Assel, A Dahlin, BY Poon, D Ulmert, H Lilja (2018). “Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men.” European urology, 73 (6), 941-948

DD Sjoberg (2014). “Toward a smarter prostate cancer screening program..” European urology, 68 (4), 598-599

MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, and others (2016). “Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer.” Journal of Clinical Oncology, 34 (23), 2705

BH Bochner, DD Sjoberg, VP Laudone (2014). “A randomized trial of robot-assisted laparoscopic radical cystectomy..” The New England journal of medicine, 371 (4), 389-390

M Nyberg, DD Sjoberg, SV Carlsson, U Wilderäng, S Carlsson, J Stranne, and others (2021). “Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial.” Bju International, 127 (3), 361

KA Touijer, DD Sjoberg, N Benfante, VP Laudone, B Ehdaie, JA Eastham, and others (2021). “Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial.” European Urology Oncology,

CR Tracy, KJ Flynn, DD Sjoberg, PT Gellhaus, CM Metz, B Ehdaie (2021). “Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores.” Urologic Oncology: Seminars and Original Investigations, 39 (3), 193. e1-193. e6

T Stonier, AL Tin, DD Sjoberg, G Jibara, AJ Vickers, S Fine, J Eastham (2021). “Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?.” The Journal of Urology, 205 (4), 1063-1068

GT Chesnut, AL Tin, DD Sjoberg, B Jang, N Benfante, S Sarraf, H Herr, and others (2021). “Electronic rapid fitness assessment identifies factors associated with adverse early postoperative outcomes following radical cystectomy.” The Journal of urology, 205 (2), 400-406

PE Lonergan, EA Vertosick, M Assel, DD Sjoberg, A Haese, M Graefen, and others (2021). “Prospective validation of microseminoprotein‐β added to the 4Kscore in predicting high‐grade prostate cancer in an international multicentre cohort.” BJU international, 128 (2), 218-224

B Ehdaie, G Jibara, DD Sjoberg, V Laudone, J Eastham, K Touijer, and others (2021). “The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized Trial.” The Journal of Urology, 10.1097/JU. 0000000000001845

RG Alvim, AL Tin, L Nogueira, NC Wong, RC Fonseca, DD Sjoberg, and others (2021). “Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management..” Urology,

H Herr, EA Vertosick, G Dalbagni, EK Cha, R Smith, N Benfante, DD Sjoberg, and others (2021). “Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder Cancer.” Urology,

N Almassi, EA Vertosick, DD Sjoberg, NC Wong, C Huang, EJ Pietzak, and others (2021). “Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.” BJU international,

GT Chesnut, AL Tin, A Sivaraman, T Takeda, T Lee, J Fainberg, DD Sjoberg, and others (2021). “Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.” Urologic Oncology: Seminars and Original Investigations,

G Jibara, DD Sjoberg, GL Stearns, Y Stabholz, A Fathollahi, LS Leddy, and others (2021). “Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.” Urology,

GT Chesnut, EA Vertosick, N Benfante, DD Sjoberg, J Fainberg, T Lee, and others (2020). “Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance.” European urology, 77 (4), 501-507

S Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter, and others (2020). “Long-term outcomes of active surveillance for prostate cancer: the Memorial Sloan Kettering Cancer Center experience.” The Journal of urology, 203 (6), 1122-1127

S Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter, and others (2020). “Risk of metastasis in men with grade group 2 prostate cancer managed with active surveillance at a tertiary cancer center.” The Journal of urology, 203 (6), 1117-1121

KA Amin, EA Vertosick, G Stearns, A Fathollahi, DD Sjoberg, MS Donat, and others (2020). “Predictors of Benign Ureteroenteric Anastomotic Strictures After Radical Cystectomy and Urinary Diversion.” Urology, 144, 225-229

N Almassi, EK Cha, EA Vertosick, C Huang, N Wong, S Dason, DD Sjoberg, and others (2020). “Trends in management and outcomes among patients with urothelial carcinoma undergoing radical cystectomy from 1995 to 2015: the Memorial Sloan Kettering experience.” The Journal of urology, 204 (4), 677-684

EA Vertosick, C Häggström, DD Sjoberg, G Hallmans, R Johansson, and others (2020). “Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years.” The Journal of urology, 204 (2), 281-288

A Vilaseca, G Guglielmetti, EA Vertosick, DD Sjoberg, A Grasso, and others (2020). “Value of partial nephrectomy for renal cortical tumors of cT2 or greater stage: a risk-benefit analysis of renal function preservation versus increased postoperative morbidity.” European urology oncology, 3 (3), 365-371

CA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio, DD Sjoberg, and others (2020). “Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy.” Urologic Oncology: Seminars and Original Investigations, 38 (4), 204-209

AJ Vickers, MJ Assel, DD Sjoberg, R Qin, Z Zhao, T Koyama, A Botchway, and others (2020). “Guidelines for reporting of figures and tables for clinical research in urology.” The Journal of Urology, 204 (1), 121-133

R Mano, EA Vertosick, J Sarcona, DD Sjoberg, NE Benfante, TF Donahue, and others (2020). “Primary urethral cancer: treatment patterns and associated outcomes.” BJU international, 126 (3), 359-366

S Dason, EK Cha, C Falavolti, EA Vertosick, LW Dean, VA McPherson, DD Sjoberg, and others (2020). “Late recurrences following radical cystectomy have distinct prognostic and management considerations.” The Journal of urology, 204 (3), 460-465

A Haese, AL Tin, SV Carlsson, DD Sjoberg, D Pehrke, T Steuber, and others (2020). “A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.” British journal of cancer, 123 (4), 604-609

GT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson, T Lee, and others (2020). “Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy.” Canadian Urological Association Journal, 14 (5), E202

JC Hu, B Ehdaie, J Sandhu, DD Sjoberg, SV Carlsson, M Tzeng, and others (2020). “Asian-American race and urinary continence after radical prostatectomy.” European Urology Open Science, 22, 51

CA Bravi, G Rosiello, G Fallara, E Vertosick, A Tin, DD Sjoberg, M Bianchi, and others (2020). “Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution..” Minerva urologica e nefrologica= The Italian journal of urology and nephrology,

S Erestam, D Bock, AE Andersson, A Bjartell, S Carlsson, KS Kollberg, DD Sjoberg, and others (2020). “Associations between intraoperative factors and surgeons’ self-assessed operative satisfaction.” Surgical endoscopy, 34 (1), 61-68

W Li, M Bicak, DD Sjoberg, E Vertosick, A Dahlin, O Melander, D Ulmert, and others (2020). “Genome‐wide association study identifies novel single nucleotide polymorphisms having age‐specific effect on prostate‐specific antigen levels.” The Prostate, 80 (16), 1405-1412

KA Touijer, DD Sjoberg, N Benfante, NP Brau, IR Belenchón, CM Barrull, and others (2020). “Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized ….” European Urology Open Science, 19, e2124

GT Chesnut, N Benfante, D Barham, LW Dean, A Tin, DD Sjoberg, and others (2020). “Routine Postoperative Hemoglobin Assessment Poorly Predicts Transfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy.” Urology practice, 7 (4), 299-304

CA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio, DD Sjoberg, and others (2020). “Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer..” Urologic oncology, 38 (4), 204

T Takeda, AL Tin, RB Corradi, R Alvim, T Hashimoto, Y Ito, DP Nguyen, DD Sjoberg, and others (2020). “Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer.” International Journal of Urology, 27 (2), 179-185

M Assel, DD Sjoberg, A Elders, X Wang, D Huo, A Botchway, K Delfino, and others (2019). “Guidelines for reporting of statistics for clinical research in urology.” The Journal of urology, 201 (3), 595-604

CA Bravi, E Vertosick, N Benfante, A Tin, DD Sjoberg, AA Hakimi, K Touijer, and others (2019). “Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy.” European urology, 76 (3), 398-403

LW Dean, M Assel, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen, and others (2019). “Clinical usefulness of total length of Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer.” The Journal of urology, 201 (1), 77-83

MA Preston, T Gerke, SV Carlsson, L Signorello, DD Sjoberg, SC Markt, and others (2019). “Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men.” European urology, 75 (3), 399-407

X Wu, H Scott, SV Carlsson, DD Sjoberg, L Cerundolo, H Lilja, R Prevo, and others (2019). “Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.” The Prostate, 79 (10), 1079-1089

Y Ito, K Udo, EA Vertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, and others (2019). “Clinical usefulness of prostate and tumor volume related parameters following radical prostatectomy for localized prostate cancer.” The Journal of urology, 201 (3), 535-540

Y Ito, EA Vertosick, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen, and others (2019). “In organ-confined prostate cancer, tumor quantitation not found to aid in prediction of biochemical recurrence.” The American journal of surgical pathology, 43 (8), 1061

P Capogrosso, EA Vertosick, NE Benfante, DD Sjoberg, AJ Vickers, and others (2019). “Can we improve the preoperative prediction of prostate cancer recurrence with multiparametric MRI?.” Clinical genitourinary cancer, 17 (4), e745-e750

GT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson, T Lee, and others (2019). “Patient experience of MRI-targeted prostate biopsy Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy..” Canadian Urological Association Journal= Journal de L’association des …,

NC Wong, RG Alvim, DD Sjoberg, R Shingarev, NE Power, M Spaliviero, and others (2019). “Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.” European urology focus, 5 (6), 977-979

M Assel, DD Sjoberg, JWF Catto, AJ Vickers (2019). “Innovations in statistical review at European Urology.” European urology, 75 (1), 1

HL Bernie, B Nascimento, D Katz, A Tin, N Benfante, DD Sjoberg, and others (2019). “160 Predictors of Worsening Erectile Function in Men With Functional Erections Early After Radical Prostatectomy.” The Journal of Sexual Medicine, 16 (4), S81

B Nascimento, HL Bernie, H Taniguchi, EP Miranda, J Terrier, S Carlsson, DD Sjoberg, and others (2019). “276 Baseline Characteristics of Treated and Untreated Patients with Peyronie’s Disease (PD).” The Journal of Sexual Medicine, 16 (4), S132

S Fine, Y Ito, E Vertosick, DD Sjoberg, A Vickers, H Al-Ahmadie, YB Chen, and others (2019). “In Organ-Confined Prostate Cancer at Radical Prostatectomy, neither Total Tumor Volume nor Maximum Tumor Diameter of the Index Lesion Aids in Prediction of Biochemical Recurrence.” LABORATORY INVESTIGATION, 99

BH Bochner, G Dalbagni, KH Marzouk, DD Sjoberg, J Lee, SM Donat, and others (2018). “Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: oncologic outcomes.” European urology, 74 (4), 465-471

KA Touijer, RJ Karnes, N Passoni, DD Sjoberg, M Assel, N Fossati, and others (2018). “Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies.” European urology, 73 (6), 890-896

M Nyberg, J Hugosson, P Wiklund, DD Sjoberg, U Wilderäng, SV Carlsson, and others (2018). “Functional and oncologic outcomes between open and robotic radical prostatectomy at 24-month follow-up in the Swedish LAPPRO trial.” European urology oncology, 1 (5), 353-360

M Spaliviero, NE Power, KS Murray, DD Sjoberg, NE Benfante, and others (2018). “Intravenous mannitol versus placebo during partial nephrectomy in patients with normal kidney function: a double-blind, clinically-integrated, randomized trial.” European urology, 73 (1), 53-59

W Li, M Middha, M Bicak, DD Sjoberg, E Vertosick, A Dahlin, and others (2018). “Genome-wide scan identifies role for AOX1 in prostate cancer survival.” European urology, 74 (6), 710-719

AD Mally, AL Tin, JK Lee, P Satasivam, EK Cha, SM Donat, HW Herr, DD Sjoberg, and others (2018). “Clinical outcomes of patients with T1 nested variant of urothelial carcinoma compared to pure urothelial carcinoma of the bladder.” Clinical genitourinary cancer, 16 (1), e23-e27

EK Cha, JP Sfakianos, R Sukhu, AM Yee, DD Sjoberg, BH Bochner (2018). “Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.” BJU international, 122 (4), 627

E Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ Stephenson (2018). “Effects of Pathologic Upstaging or Upgrading on Metastasis and Cancer-Specific Mortality in men with Clinical Low-risk Prostate Cancer.” BJU international, 122 (6), 1003

T Takeda, AL Tin, RB Corradi, M Mamoor, NE Benfante, DD Sjoberg, and others (2018). “Topography of prostate cancer recurrence after radiation therapy: a detailed mapping study of salvage radical prostatectomy specimens.” European urology, 73 (4), 488-490

K Marzouk, A Tin, N Liu, DD Sjoberg, AA Hakimi, P Russo, J Coleman (2018). “The natural history of large renal masses followed on observation.” Urologic Oncology: Seminars and Original Investigations, 36 (8), 362. e17-362 …

M Rieken, LA Kluth, H Fajkovic, U Capitanio, A Briganti, LM Krabbe, DD Sjoberg, and others (2018). “Predictors of cancer-specific survival after disease recurrence in patients with renal cell carcinoma: the effect of time to recurrence.” Clinical genitourinary cancer, 16 (4), e903-e908

RG Alvim, F Audenet, EA Vertosick, DD Sjoberg, KA Touijer (2018). “Performance prediction for surgical outcomes in partial nephrectomy using nephrometry scores: a comparison of arterial based complexity (ABC), RENAL, and PADUA systems.” European urology oncology, 1 (5), 428-434

CM Dowling, M Assel, JE Musser, JJ Meeks, DD Sjoberg, G Bosl, and others (2018). “Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen.” Urology, 114, 133-138

A Bagrodia, R Sukhu, AG Winer, E Levy, M Vacchio, B Lee, EJ Pietzak, DD Sjoberg, and others (2018). “Incidence and effect of thromboembolic events in radical cystectomy patients undergoing preoperative chemotherapy for muscle-invasive bladder cancer.” Clinical genitourinary cancer, 16 (1), e113-e120

AJ Vickers, EA Vertosick, DD Sjoberg (2018). “Value of a statistical model based on four kallikrein markers in blood, commercially available as 4Kscore, in all reasonable prostate biopsy subgroups.” European urology, 74 (4), 535

L Marconi, R de Bruijn, E van Werkhoven, C Beisland, K Fife, DD Sjoberg, and others (2018). “External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.” World journal of urology, 36 (12), 1973-1980

A Vickers, EA Vertosick, DD Sjoberg, F Hamdy, D Neal, A Bjartell, and others (2018). “Value of intact prostate specific antigen and human kallikrein 2 in the 4 kallikrein predictive model: an individual patient data meta-analysis.” The Journal of urology, 199 (6), 1470-1474

JK Lee, DD Sjoberg, MI Miller, AJ Vickers, JP Mulhall, B Ehdaie (2018). “Improved recovery of erectile function in younger men after radical prostatectomy: Does it justify immediate surgery in low-risk patients?.” European urology, 73 (1), 33-37

P Capogrosso, A Larcher, DD Sjoberg, EA Vertosick, F Cianflone, and others (2018). “Risk based surveillance after surgical treatment of renal cell carcinoma.” The Journal of urology, 200 (1), 61-67

F Audenet, EA Vertosick, SW Fine, DD Sjoberg, AJ Vickers, VE Reuter, and others (2018). “Biopsy core features are poor predictors of adverse pathology in men with grade group 1 prostate cancer.” The Journal of urology, 199 (4), 961-968

M Ghanaat, AG Winer, DD Sjoberg, BY Poon, M Kashan, AL Tin, and others (2018). “Comparison of postradical cystectomy ileus rates using GIA-80 versus GIA-60 intestinal stapler device.” Urology, 122, 121-126

KS Murray, EA Vertosick, M Spaliviero, JW Mashni Jr, DD Sjoberg, and others (2018). “Importance of wide re‐resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution.” Journal of surgical oncology, 117 (7), 1464-1468

K Lapen, L Benusis, S Pearson, B Search, M Coleton, QS Li, DD Sjoberg, and others (2018). “A feasibility study of restorative yoga versus vigorous yoga intervention for sedentary breast and ovarian cancer survivors.” International journal of yoga therapy, 28 (1), 79-85

DP Nguyen, EA Vertosick, V Sharma, RB Corradi, A Vilaseca, T Takeda, DD Sjoberg, and others (2018). “Does subclassification of pathologically organ confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?.” The Journal of urology, 199 (6), 1502-1509

EJ Pietzak, M Assel, MF Becerra, D Tennenbaum, DR Feldman, DD Sjoberg, and others (2018). “Histologic and oncologic outcomes following liver mass resection with retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumor.” Urology, 118, 114-118

AE Thong, BY Poon, JK Lee, E Vertosick, DD Sjoberg, AJ Vickers, and others (2018). “Concordance between patient-reported and physician-reported sexual function after radical prostatectomy.” Urologic Oncology: Seminars and Original Investigations, 36 (2), 80. e1-80. e6

LW Dean, M Assel, DD Sjoberg, AJ Vickers, HA Al-Ahmadie, YB Chen, and others (2018). “Clinical utility of total length Gleason pattern 4 on biopsy in men with grade group 2 prostate cancer.” J Urol, 10

E Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ Stephenson (2018). “Re: Effects of Pathological Upstaging or Upgrading on Metastasis and Cancer-Specific Mortality in Men with Clinical Low-Risk Prostate Cancer Editorial Comment.” JOURNAL OF UROLOGY, 200 (5), 945-946

AJ Vickers, H Lilja, Y Dong, DD Sjoberg, PT Scardino (2018). “Composiciones y métodos para la vigilancia activa del cáncer de próstata..” ,

Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2018). “Composiciones y metodos para la vigilancia activa del cancer de prostata.” ,

H Lilja, PT Scardino, AJ Vickers, Y Dong, DD Sjoberg (2018). “Sistemas y métodos para la vigilancia activa del cancer de próstata.” ,

NT John, A Tin, RG Dinatale, NE Benfante, DD Sjoberg, AA Hakimi, and others (2018). “Genomic Predictors of Response to Neoadjuvant Cisplatin-based Chemotherapy in Upper Tract Urothelial Carcinoma (UTUC).” JOURNAL OF UROLOGY, 199 (4), E216-E216

NT John, A Tin, DD Sjoberg, N Benfante, AA Hakimi, P Russo, J Coleman (2018). “Can Imaging Response following Neoadjuvant Chemotherapy in Upper Tract Urothelial Cancer be a Surrogate for Pathologic Response?.” JOURNAL OF UROLOGY, 199 (4), E214-E215

SW Fine, H Al-Ahmadie, E Vertosick, DD Sjoberg, A Vickers, YB Chen, and others (2018). “Impact of Zone of Origin in Anterior-Dominant Prostatic Tumors: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Annotated Series.” LABORATORY INVESTIGATION, 98, 340-340

DW Lin, LF Newcomb, MD Brown, DD Sjoberg, Y Dong, JD Brooks, and others (2017). “Evaluating the four kallikrein panel of the 4Kscore for prediction of high-grade prostate cancer in men in the canary prostate active surveillance study.” European urology, 72 (3), 448-454

K Mooney, DL Berry, M Whisenant, DD Sjoberg (2017). “Improving cancer care through the patient experience: how to use patient-reported outcomes in clinical practice.” American Society of Clinical Oncology Educational Book, 37, 695-704

MJ O’Shaughnessy, SM McBride, HA Vargas, KA Touijer, MJ Morris, DD Sjoberg, and others (2017). “A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer.” Urology, 102, 164-172

R Chen, DD Sjoberg, Y Huang, L Xie, L Zhou, D He, AJ Vickers, Y Sun (2017). “Prostate specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies compared with Western cohorts.” The Journal of urology, 197 (1), 90-96

M Assel, DD Sjoberg, AJ Vickers (2017). “The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models.” Diagnostic and prognostic research, 1 (1), 1-7

BJ Manley, DM Tennenbaum, EA Vertosick, JJ Hsieh, DD Sjoberg, and others (2017). “The difficulty in selecting patients for cytoreductive nephrectomy: an evaluation of previously described predictive models.” Urologic Oncology: Seminars and Original Investigations, 35 (1), 35. e1-35. e5

A Vickers, EA Vertosick, DD Sjoberg, MJ Roobol, F Hamdy, D Neal, and others (2017). “Properties of the 4-kallikrein panel outside the diagnostic gray zone: meta-analysis of patients with positive digital rectal examination or prostate specific antigen 10 ng/ml ….” The Journal of urology, 197 (3), 607-613

EH Kim, GL Andriole, ED Crawford, DD Sjoberg, M Assel, AJ Vickers, and others (2017). “Detection of high grade prostate cancer among PLCO participants using a prespecified 4-kallikrein marker panel.” The Journal of urology, 197 (4), 1041-1047

SM Zappala, Y Dong, V Linder, M Reeve, DD Sjoberg, V Mathur, and others (2017). “The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information.” International journal of clinical practice, 71 (6), e12943

A Vilaseca, DP Nguyen, EA Vertosick, RB Corradi, M Musquera, M Pérez, DD Sjoberg, and others (2017). “Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.” World journal of urology, 35 (1), 51-56

A Polland, EA Vertosick, DD Sjoberg, GL Stearns, LS Leddy, and others (2017). “Preoperative symptoms predict continence after post-radiation transurethral resection of prostate..” The Canadian journal of urology, 24 (4), 8903-8909

S Punnen, B Nahar, NS Prakash, DD Sjoberg, SM Zappala, DJ Parekh (2017). “The 4Kscore predicts the grade and stage of prostate cancer in the radical prostatectomy specimen: results from a multi-institutional prospective trial.” European urology focus, 3 (1), 94-99

RB Corradi, EA Vertosick, DP Nguyen, A Vilaseca, DD Sjoberg, and others (2017). “Nephrometry scores and perioperative outcomes following robotic partial nephrectomy.” International braz j urol, 43, 1075-1083

AG Winer, EA Vertosick, M Ghanaat, RB Corradi, S Carlsson, DD Sjoberg, and others (2017). “Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.” Urologic Oncology: Seminars and Original Investigations, 35 (4), 151. e9-151. e15

G Dalbagni, N Benfante, DD Sjoberg, BH Bochner, S Machele Donat, and others (2017). “Single arm phase I/II study of everolimus and intravesical gemcitabine in patients with primary or secondary carcinoma in situ of the bladder who failed bacillus Calmette ….” Bladder Cancer, 3 (2), 113-119

Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2017). “Compositions and methods for active surveillance of prostate cancer.” US Patent App., 15/143,345

DP Nguyen, M Kent, A Vilaseca, RB Corradi, N Fossati, DD Sjoberg, and others (2017). “Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.” Prostate cancer and prostatic diseases, 20 (1), 105-109

LH Rosenberger, R Weber, DD Sjoberg, AJ Vickers, DA Mangino, and others (2017). “Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on ….” Breast cancer research and treatment, 162 (2), 275-282

JI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, and others (2016). “A contemporary prostate cancer grading system: a validated alternative to the Gleason score.” European urology, 69 (3), 428-435

K Braun, DD Sjoberg, AJ Vickers, H Lilja, AS Bjartell (2016). “A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort.” European urology, 69 (3), 505-511

P Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K Touijer, and others (2016). “The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active ….” The Journal of urology, 196 (2), 374-381

M Spaliviero, BY Poon, CA Karlo, GB Guglielmetti, PL Di Paolo, DD Sjoberg, and others (2016). “An arterial based complexity (ABC) scoring system to assess the morbidity profile of partial nephrectomy.” European urology, 69 (1), 72-79

DP Nguyen, EA Vertosick, RB Corradi, A Vilaseca, NE Benfante, DD Sjoberg, and others (2016). “Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.” Urologic Oncology: Seminars and original investigations, 34 (6), 259. e1-259. e8

M Imnadze, DD Sjoberg, AJ Vickers (2016). “Adverse pathologic features at radical prostatectomy: effect of preoperative risk on oncologic outcomes.” European urology, 69 (1), 143-148

CD Jakubowski, EA Vertosick, BR Untch, DD Sjoberg, E Wei, FL Palmer, and others (2016). “Complete metastasectomy for renal cell carcinoma: comparison of five solid organ sites.” Journal of surgical oncology, 114 (3), 375-379

DJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA Eastham, and others (2016). “Comparative effectiveness of targeted prostate biopsy using magnetic resonance imaging ultrasound fusion software and visual targeting: a prospective study.” The Journal of urology, 196 (3), 697-702

C Anderson, R Weber, D Patel, W Lowrance, A Mellis, M Cookson, DD Sjoberg, and others (2016). “A 10-item checklist improves reporting of critical procedural elements during transurethral resection of bladder tumor.” The Journal of urology, 196 (4), 1014-1020

A Sankin, AL Tin, R Mano, M Chevinsky, C Jakubowski, JP Sfakianos, DD Sjoberg, and others (2016). “Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.” Urology, 94, 148-153

N Fossati, NM Passoni, M Moschini, G Gandaglia, A Larcher, M Freschi, DD Sjoberg, and others (2016). “Impact of stage migration and practice changes on high risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.” BJU international, 117 (5), 740

LV Selby, M Sovel, DD Sjoberg, M McSweeney, D Douglas, DR Jones, and others (2016). “Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism.” Journal of the American College of Surgeons, 222 (2), 129-137

R Mano, EA Vertosick, AA Hakimi, IA Sternberg, DD Sjoberg, M Bernstein, and others (2016). “The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4 cm.” Urologic Oncology: Seminars and Original Investigations, 34 (5), 239. e1-239. e8

WM Bazzi, AL Tin, DD Sjoberg, M Bernstein, P Russo (2016). “The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma.” The Canadian journal of urology, 23 (1), 8151

NW Liu, JD Wren, E Vertosick, JK Lee, NE Power, NE Benfante, SY Kimm, DD Sjoberg, and others (2016). “The prognostic impact of a positive vascular margin on pT3 clear cell renal cell carcinoma.” The Journal of urology, 195 (2), 264-269

A Rönnblom, T Holmström, H Tanghöj, U Karlbom, M Thörn, D Sjöberg (2016). “Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009.” Scandinavian journal of gastroenterology, 51 (11), 1339-1344

P Recabal, M Assel, JE Musser, RJ Caras, DD Sjoberg, JA Coleman, and others (2016). “Erectile function recovery after radical prostatectomy in men with high risk features.” The Journal of urology, 196 (2), 507-513

A Ronnblom, T Holmstrom, H Tanghoj, U Karlbom, M Thorn, DD Sjoberg (2016). “Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.” Scandinavian Journal of Gastroenterology, 51 (11), 1339-1344

B Ehdaie, BY Poon, DD Sjoberg, P Recabal, V Laudone, K Touijer, and others (2016). “Variation of serum prostate-specific antigen in men with prostate cancer managed with active surveillance.” BJU international, 118 (4), 535

DP Nguyen, A Vilaseca, EA Vertosick, RB Corradi, KA Touijer, DD Sjoberg, and others (2016). “Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.” World journal of urology, 34 (4), 539-544

DJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA Eastham, and others (2016). “Comparative effectiveness of targeted prostate biopsy using MRI-US fusion software and visual targeting: a prospective study.” The Journal of urology, 196 (3), 697

CB Anderson, AL Tin, DD Sjoberg, JP Mulhall, J Sandhu, VP Laudone, and others (2016). “Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.” BJU international, 117 (6B), E46

G Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD Sjoberg, JA Eastham, and others (2016). “Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.” Actas Urológicas Españolas (English Edition), 40 (7), 434-439

P Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K Touijer, and others (2016). “The efficacy of multiparametric magnetic resonance imaging and MRI-targeted biopsy in risk classification for patients with prostate cancer on active surveillance.” The Journal of urology, 196 (2), 374

Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2016). “Compositions and methods for active surveillance of prostate cancer.” US Patent App., 15/143,329

MA Feuerstein, JE Musser, M Kent, M Chevinsky, EK Cha, S Kimm, DD Sjoberg, and others (2016). “Low yield of surveillance imaging after surgery for T1 kidney cancer.” World journal of urology, 34 (7), 949-953

A Vilaseca Cabo, D Nguyen, A Tin, R Corradi, A Martin-Malburet, DD Sjoberg, and others (2016). “433 Long-term oncological outcomes of salvage radical prostatectomy for radio-recurrent/persistent prostate cancer after radiation therapy.” EUROPEAN UROLOGY-SUPPLEMENTS-, 15 (3), e433-e433

G Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD Sjoberg, JA Eastham, and others (2016). “Número de ganglios linfáticos metastásicos como determinante de los resultados de la prostatectomía radical de rescate en el cáncer de próstata de recidivante tras radioterapia.” Actas urologicas espanolas, 40 (7), 434-439

D Lin, M Brown, L Newcomb, DD Sjoberg, J Brooks, P Carroll, A Dash, and others (2016). “PD08-02 evaluating the four kallikrein panel of the 4kscore for prediction of high-grade prostate cancer in men in the canary prostate active surveillance study (PASS).” The Journal of Urology, 195 (4S), e229-e229

Y Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja (2016). “Compositions and methods for active surveillance of prostate cancer.” ,

J Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, and others (2016). “A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score (Retraction of Vol 69, Pg 428, 2016).” PATHOLOGY INTERNATIONAL, 66 (10), 600-+

M Imnadze, DD Sjoberg, J Lee, LC Jenkins, A Vickers, JP Mulhall, B Ehdaie (2016). “050 Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Intervention in Low-Risk Patients?.” The Journal of Sexual Medicine, 13 (5), S24

BH Bochner, G Dalbagni, DD Sjoberg, J Silberstein, GEK Paz, SM Donat, and others (2015). “Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial.” European urology, 67 (6), 1042-1050

DJ Parekh, S Punnen, DD Sjoberg, SW Asroff, JL Bailen, JS Cochran, and others (2015). “A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.” European urology, 68 (3), 464-470

RJ Bryant, DD Sjoberg, AJ Vickers, MC Robinson, R Kumar, L Marsden, and others (2015). “Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.” JNCI: Journal of the National Cancer Institute, 107 (7)

P Stattin, AJ Vickers, DD Sjoberg, R Johansson, T Granfors, M Johansson, and others (2015). “Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case–control study.” European urology, 68 (2), 207-213

AJ Vickers, DD Sjoberg (2015). “Guidelines for reporting of statistics in European Urology.” Eur Urol, 67 (2), 181-187

LV Selby, EA Vertosick, DD Sjoberg, MA Schattner, YY Janjigian, and others (2015). “Morbidity after total gastrectomy: analysis of 238 patients.” Journal of the American College of Surgeons, 220 (5), 863-871. e2

JK Lee, M Assel, AE Thong, DD Sjoberg, JP Mulhall, J Sandhu, and others (2015). “Unexpected long-term improvements in urinary and erectile function in a large cohort of men with self-reported outcomes following radical prostatectomy.” European urology, 68 (5), 899-905

M Spaliviero, BY Poon, O Aras, PL Di Paolo, GB Guglielmetti, DD Sjoberg, and others (2015). “Interobserver variability of RENAL, PADUA, and centrality index nephrometry score systems.” World journal of urology, 33 (6), 853-858

KM Wesa, NH Segal, AM Cronin, DD Sjoberg, GN Jacobs, MI Coleton, and others (2015). “Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis.” Nutrition and cancer, 67 (3), 424-430

WM Bazzi, DD Sjoberg, MA Feuerstein, A Maschino, S Verma, and others (2015). “Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.” The Journal of urology, 193 (6), 1911-1917

M Chevinsky, M Imnadze, A Sankin, A Winer, R Mano, C Jakubowski, DD Sjoberg, and others (2015). “Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.” The Journal of urology, 194 (2), 310-315

R Mano, M Kent, Y Larish, AG Winer, MS Chevinsky, AA Hakimi, DD Sjoberg, and others (2015). “Partial and radical nephrectomy for unilateral synchronous multifocal renal cortical tumors.” Urology, 85 (6), 1404-1410

CB Anderson, IA Sternberg, G Karen-Paz, PH Kim, DD Sjoberg, HA Vargas, and others (2015). “Age is associated with upgrading at confirmatory biopsy among men with prostate cancer treated with active surveillance.” The Journal of urology, 194 (6), 1607-1611

JL Silberstein, SA Poon, DD Sjoberg, AC Maschino, AJ Vickers, A Bernie, and others (2015). “Long term oncologic outcomes of a Phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk ….” BJU international, 116 (1), 50

TP Ghoneim, DD Sjoberg, W Lowrance, SF Shariat, C Savage, and others (2015). “Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics.” World journal of urology, 33 (12), 2023-2029

R Mano, E Vertosick, AI Sankin, MS Chevinsky, Y Larish, CD Jakubowski, DD Sjoberg, and others (2015). “Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.” The Journal of urology, 193 (3), 776-782

WM Bazzi, DD Sjoberg, AAC Grasso, M Bernstein, R Parra, JA Coleman (2015). “Predicting length of stay after robotic partial nephrectomy.” International urology and nephrology, 47 (8), 1321-1325

LV Selby, DD Sjoberg, D Cassella, M Sovel, MR Weiser, K Sepkowitz, and others (2015). “Comparing surgical infections in national surgical quality improvement project and an institutional database.” Journal of Surgical Research, 196 (2), 416-420

T Gondo, BY Poon, K Matsumoto, M Bernstein, DD Sjoberg, JA Eastham (2015). “Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+ 4 prostate cancer.” BJU international, 115 (1), 81

WM Bazzi, LY Chen, BH Cordon, J Mashni, DD Sjoberg, M Bernstein, and others (2015). “Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.” International urology and nephrology, 47 (9), 1499-1502

N Fossati, A Larcher, GM Gadda, DD Sjoberg, FA Mistretta, P Dell’Oglio, and others (2015). “Minimally invasive partial nephrectomy versus laparoscopic cryoablation for patients newly diagnosed with a single small renal mass.” European urology focus, 1 (1), 66-72

JE Musser, MJ Assel, JJ Meeks, DD Sjoberg, AJ Vickers, JA Coleman, and others (2015). “Ambulatory extended recovery: safely transitioning to overnight observation for minimally invasive prostatectomy.” Urology Practice, 2 (3), 121-125

C Eriksson, S Almer, JA Bjork, M Eberhardson, A Eriksson, O Grip, DD Sjoberg, and others (2015). “Vedolizumab in inflammatory bowel disease, the first experience from the Swedish IBD Registry (SWIBREG).” Gastroenterology, 148 (4), S871-S871

N Fossati, DD Sjoberg, U Capitanio, G Gandaglia, A Larcher, A Nini, and others (2015). “Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.” BJU international, 116 (3), 366-372

M Cesarini, G Collins, A Ronnblom, A Santos, DD Sjoberg, M Parkes, and others (2015). “Predicting the risk of acute severe colitis (ASC) at diagnosis of Ulcerative Colitis (UC): external validation.” Journal of Crohn’s and Colitis, 9 (suppl 1)

AJ Vickers, DD Sjoberg (2015). “Decision analysis of dutasteride use for patients with negative prostate biopsy.” Urology, 85 (2), 337-342

A Bondarik, D Sjöberg (2015). “Implementation of UC-EBG structure for 60 GHz gridded parasitic patch stacked microstrip antenna.” , 2015 9th European Conference on Antennas and Propagation (EuCAP), 1-5

S Punnen, DD Sjoberg, SM Zappala, D Parekh (2015). “A multi-institutional prospective trial in the United States to confirm the 4Kscore identification of men with high-grade prostate cancer.” JOURNAL OF CLINICAL ONCOLOGY, 33 (7)

JL Silberstein, SA Poon, DD Sjoberg (2015). “Neoadjuvante Chemohormontherapie vor radikaler Prostatektomie?.” Urologie Scan, 2 (04), 251-251

BH Bochner, G Dalbagni, DD Sjoberg (2015). “Offen chirurgische versus roboterassistierte laparoskopische radikale Zystektomie.” Urologie Scan, 2 (04), 247-247

R Mano, E Vertosick, A Sankin, M Chevinsky, Y Larish, C Jakubowski, DD Sjoberg, and others (2015). “Re: Subcentimeter Pulmonary Nodules are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma.” The Journal of Urology, 194 (3), 851-852

EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, DD Sjoberg, M Assel, and others (2014). “Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.” European urology, 66 (3), 489-499

KA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA Eastham (2014). “Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.” European urology, 65 (1), 20-25

S Carlsson, M Assel, DD Sjoberg, D Ulmert, J Hugosson, H Lilja, A Vickers (2014). “Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.” Bmj, 348

AJ Vickers, DD Sjoberg, D Ulmert, E Vertosick, MJ Roobol, I Thompson, and others (2014). “Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.” BMC medicine, 12 (1), 1-7

M Spaliviero, G Dalbagni, BH Bochner, BY Poon, H Huang, DD Sjoberg, and others (2014). “Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.” The Journal of urology, 192 (3), 702-707

K Braun, Y Ahallal, DD Sjoberg, T Ghoneim, M Dominguez Esteban, and others (2014). “Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer.” The Journal of urology, 191 (3), 744-749

M Matignon, R Ding, DM Dadhania, FB Mueller, C Hartono, DD Sjoberg, and others (2014). “Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.” Journal of the American Society of Nephrology, 25 (7), 1586-1597

T Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J Coleman, P Russo (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191 (5), 1225-1230

T Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J Coleman, P Russo (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191 (5), 1225-1230

JE Musser, M Assel, JW Mashni, DD Sjoberg, P Russo (2014). “Adult prostate sarcoma: the Memorial Sloan Kettering experience.” Urology, 84 (3), 624-628

PH Kim, R Sukhu, BH Cordon, JP Sfakianos, DD Sjoberg, AA Hakimi, and others (2014). “Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in bladder cancer patients with negative surveillance cystoscopy.” BJU international, 114 (3), 354

S Carlsson, A Berglund, DD Sjoberg, A Khatami, J Stranne, S Bergdahl, and others (2014). “Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.” BMC urology, 14 (1), 1-8

SK Hong, BY Poon, DD Sjoberg, PT Scardino, JA Eastham (2014). “Prostate size and adverse pathologic features in men undergoing radical prostatectomy.” Urology, 84 (1), 153-157

KA Moses, LY Chen, DD Sjoberg, M Bernstein, KA Touijer (2014). “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.” BMC urology, 14 (1), 1-6

JE Musser, M Assel, GB Guglielmetti, P Pathak, JL Silberstein, DD Sjoberg, and others (2014). “Impact of routine use of surgical drains on incidence of complications with robot-assisted radical prostatectomy.” Journal of endourology, 28 (11), 1333-1337

SK Hong, E Vertosick, DD Sjoberg, PT Scardino, JA Eastham (2014). “Insignificant disease among men with intermediate-risk prostate cancer.” World journal of urology, 32 (6), 1417-1421

M Rieken, RS Djajadiningrat, LA Kluth, RL Favaretto, E Xylinas, DD Sjoberg, and others (2014). “Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.” European urology, 66 (5), 811-814

B Ehdaie, DD Sjoberg, PH Dalecki, PT Scardino, JA Eastham, D Amar (2014). “Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study.” Canadian Journal of Anesthesia/Journal canadien d’anesthésie, 61 (12), 1068-1074

S Carlsson, M Assel, DD Sjoberg (2014). “L’effet du dépistage du cancer de la prostate, dépend-il du taux du PSA à l’âge de 60 ans?.” Minerva, 13 (10), 123-124

SW Fine, J Chang, JB Poon, DD Sjoberg, HA Al-Ahmadie, YB Chen, and others (2014). “Gleason Score 7 with Tertiary Pattern 5: A Contemporary Analysis.” LABORATORY INVESTIGATION, 94, 227A-228A

AJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson, and others (2013). “Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.” Bmj, 346

BR Cassileth, KJ Van Zee, KS Yeung, MI Coleton, S Cohen, YH Chan, DD Sjoberg, and others (2013). “Acupuncture in the treatment of upper‐limb lymphedema: Results of a pilot study.” Cancer, 119 (13), 2455-2461

M Rink, DJ Lee, M Kent, E Xylinas, HM Fritsche, M Babjuk, A Brisuda, DD Sjoberg, and others (2013). “Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy.” BJU international, 111 (3b), E30-E36

V Margulis, SF Shariat, Y Rapoport, M Rink, DD Sjoberg, NM Tannir, and others (2013). “Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.” European urology, 63 (5), 947-952

A Christensson, C Savage, DD Sjoberg, AM Cronin, M Frank O’Brien, and others (2013). “Association of cancer with moderately impaired renal function at baseline in a large, representative, population‐based cohort followed for up to 30 years.” International journal of cancer, 133 (6), 1452-1458

G Deng, Y Chan, DD Sjoberg, A Vickers, KS Yeung, M Kris, D Straus, and others (2013). “Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial.” Supportive Care in Cancer, 21 (6), 1735-1741

SV Carlsson, LJ Tafe, DC Chade, DD Sjoberg, N Passoni, SF Shariat, and others (2013). “Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.” The Journal of urology, 189 (4), 1314-1319

JA Forsberg, DD Sjoberg, QR Chen, A Vickers, JH Healey (2013). “Treating metastatic disease: which survival model is best suited for the clinic?.” Clinical Orthopaedics and Related Research®, 471 (3), 843-850

G Deng, WD Wong, J Guillem, Y Chan, T Affuso, KS Yeung, M Coleton, DD Sjoberg, and others (2013). “A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus.” Annals of surgical oncology, 20 (4), 1164-1169

AA Hakimi, L Chen, PH Kim, DD Sjoberg, L Glickman, MR Walker, P Russo (2013). “The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma.” Canadian Urological Association Journal, 7 (11-12), E687

AJ Vickers, DD Sjoberg, DP Ankerst, CM Tangen, PJ Goodman, and others (2013). “The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate‐specific antigen and biopsy outcome.” Cancer, 119 (16), 3007-3011

S Carlsson, M Peltola, DD Sjoberg, F Schröder, J Hugosson, K Pettersson, and others (2013). “Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?.” BJU international, 112 (5), 602

JL Silberstein, PC Sprenkle, D Su, NE Power, TV Tarin, P Ezell, DD Sjoberg, and others (2013). “Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model.” BJU international, 112 (4), 517

KA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA Eastham (2013). “Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth’s letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A ….” European urology, 65 (2), e25-6

W Breitbart, S Poppito, B Rosenfeld, AJ Vickers, Y Li, J Abbey, M Olden, DD Sjoberg, and others (2012). “Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer.” Journal of clinical oncology, 30 (12), 1304

TV Tarin, NE Power, B Ehdaie, JP Sfakianos, JL Silberstein, CJ Savage, DD Sjoberg, and others (2012). “Lymph node–positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.” European urology, 61 (5), 1025-1030

M Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, RK Lee, J Hansen, and others (2012). “Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.” Annals of surgical oncology, 19 (13), 4337-4344

A Sankin, JP Sfakianos, J Schiff, DD Sjoberg, JA Coleman (2012). “Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate.” Urology, 80 (2), 343-346

AJ Vickers, DD Sjoberg, E Basch, F Sculli, M Shouery, V Laudone, and others (2012). “How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy.” European urology, 61 (2), 284

Y Ahallal, K Braun, DD Sjoberg, T Ghoneim, M Esteban, J Mulhall, and others (2012). “Impact des biopsies répétées sur la fonction érectile chez les patients sous surveillance active pour cancer de la prostate.” Progrès en Urologie, 22 (13), 810

M Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, R Lee, J Hansen, and others (2012). “Time to Disease Recurrence is a Predictor of Cancer-Specific Mortality After Radical Nephroureterectomy.” UROLOGY, 80 (3), S332-S332

HF Hochberg-Garrett, DM Hoelscher, SV Sharma, DD Sjoberg (2009). “The Skip to Breakfast Project: Development, Implementation, and Evaluation of an Intervention to Increase Healthful Breakfast Consumption among Fifth Grade Students and Their ….” Journal of the American Dietetic Association, 109 (9), A81